Xeris Biopharma benefits from the FDA's CRL to Corcept's relacorilant, removing a major competitive threat to Recorlev sales ...

Patent protection for semaglutide expires in India in March 2026, triggering a rush among Indian drugmakers to prepare ...

Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this ...

AI-powered edtech leader expands its catalogue with data-driven precision, delivering urgent workforce upskilling ...

New capability allows brands to generate thousands of personalized event invitations from existing video libraries ...

Citi Research said Lupin's $90-million patent settlement with Astellas Pharma may prevent other generic drugmakers from launching generic Mirabegron for an extended period, potentially giving Lupin ...

Apple’s 2026 Studio Displays are here, but they come with strict macOS Tahoe requirements. Find out if your older Mac or ...

The media company controlled by the Ellisons out-dueled Netflix for control of Warner Bros. Discovery. The next step is ...

Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...

Based on the Server Slam weekend, Marathon is a wildly inconsistent game that hits blood-pumping highs in between rounds of pure frustration.

Before anyone’s hopes get too high, the whole inbox zero concept doesn’t work the way you think it does. Email is a fact of ...

Outlining four developments set to change how life-sciences organizations design, deploy, and govern intelligent systems in the year ahead.